Menu Search
Equities

Europlasma SA

1EZ:BER

Europlasma SA

Actions
  • Price (EUR)0.049
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-99.97%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 18:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Europlasma SA grew revenues 6.10% from 14.52m to 15.41m while net income improved from a loss of 15.93m to a smaller loss of 14.74m.
Gross margin10.61%
Net profit margin-42.46%
Operating margin-25.32%
Return on assets-16.12%
Return on equity-291.20%
Return on investment-38.26%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Europlasma SA fell by 1.26m. Cash Flow from Financing totalled 9.67m or 62.77% of revenues. In addition the company used 9.97m for operations while cash used for investing totalled 953.00k.
Cash flow per share-0.0011
Price/Cash flow per share--
Book value per share2.89
Tangible book value per share2.82
More ▼

Balance sheet in EURView more

Europlasma SA has a Debt to Total Capital ratio of 56.36%, a lower figure than the previous year's 866.67%.
Current ratio0.7408
Quick ratio0.3494
Total debt/total equity1.14
Total debt/total capital0.5636
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.